41 Results for "

Flt-3-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "Flt-3-IN-1" in MCE Product Catalog:

Cat. No.: HY-178444
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

Flt-3-IN-1 is a potent FLT-3 inhibitor with an IC50 of 0.91 μM. Flt-3-IN-1 can cause leukemia cells G1 phase arrest and induce apoptosis. Flt-3-IN-1 can be used for the research of cancer, such as leukemia .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-101549
CAS No.: 1429882-07-4
Purity:  99.70%
Synonyms: UNC2371
Target:  

FLT3

Research Areas:  

Cancer

MRX-2843 (UNC2371) is an orally active, ATP-competitive dual MERTK and FLT3 tyrosine kinases inhibitor (TKI) with enzymatic IC50s of 1.3 nM for MERTK and 0.64 nM for FLT3, respectively .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-15166B
CAS No.: 1204918-73-9
Purity:  98.06%
Synonyms: (E/Z)-TG02 citrate; (E/Z)-SB1317 citrate
Target:  

CDK JAK FLT3

Research Areas:  

Cancer

(E/Z)-Zotiraciclib citrate is a potent CDK2, JAK2, and FLT3 inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130247
CAS No.: 2387765-27-5
Purity:  99.48%
Synonyms: JAK2/Flt3-IN-1
Target:  

JAK FLT3 Apoptosis

Research Areas:  

Cancer

Flonoltinib is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. Flonoltinib has anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0791
CAS No.: 1345847-93-9
Synonyms: DCC-2701
Research Areas:  

Cancer

Altiratinib (DCC-2701) is a multi-targeted kinase inhibitor with IC50s of 2.7, 8, 9.2, 9.3, 0.85, 4.6, 0.83 nM for MET, TIE2, VEGFR2, FLT3, Trk1, Trk2, and Trk3 respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130247A
CAS No.: 2928093-29-0
Purity:  99.77%
Synonyms: JAK2/Flt3-IN-1 TFA
Target:  

JAK FLT3 Apoptosis

Research Areas:  

Cancer

Flonoltinib TFA is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. Flonoltinib TFA has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-12960
CAS No.: 1370256-78-2
Purity:  99.20%
Synonyms: Flt3-​IN-​1
Target:  

FLT3 c-Kit Apoptosis

Research Areas:  

Cancer

SKLB4771 is a potent and selective Flt3 inhibitor with an IC50 value of 10 nM. SKLB4771 downregulates the phosphorylation of FLT3/STAT5/ERK, blocks cell proliferation, and induces apoptosis in tumor tissue .
loading...
    loading...
Cat. No.: HY-114323
CAS No.: 2230826-81-8
Purity:  99.74%
PROTAC FLT-3 degrader 1 is an effective and selective FLT-3 PROTAC degrader with an IC50 of 0.6 nM. PROTAC FLT-3 degrader 1 inhibits both FLT-3 and FLT-3 ITD mutants. PROTAC FLT-3 degrader 1 has the activity of anti-proliferation and induction of apoptosis, which can be used in the study of tumor .
loading...
    loading...
Cat. No.: HY-109179
CAS No.: 1628870-27-8
Purity:  99.06%
Synonyms: TP-0184
Itacnosertib (TP-0184) is the inhibitor for FLT3, ACVR1 (ALK2, IC50=8 nM) and JAK2 (IC50=8540 nM). Itacnosertib exhibits anti-leukemic activity .
loading...
    loading...
Cat. No.: HY-P5438
Research Areas:  

Others

Srctide is a biological active peptide. (This is a peptide substrate for many protein kinases, such as Blk, BTK, cKit, EPHA1, EPHB2, EPHB3, ERBB4, FAK, Flt3, IGF-1R, ITK, Lck, MET, MUSK, Ret, Src, TIE2, TrkB, VEGF-R1 (Flt-1) and VEGF-R2 (KDR).)
loading...
    loading...
Cat. No.: HY-19897
CAS No.: 895533-09-2
Target:  

FLT3 VEGFR

Research Areas:  

Cancer

4SC-203 is a potent multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively FLT3/STK1, FLT3 mutated forms, and VEGFRs .
loading...
    loading...
Cat. No.: HY-159953
CAS No.: 2760328-82-1
Target:  

IRAK FLT3

Research Areas:  

Inflammation/Immunology Cancer

IRAK1/4/pan-FLT3 Kinase-IN-1 is an orally active, potent and selective IRAK/pan-FLT3 kinase inhibitor with IC50s of 5 nM, 0.6 nM and <0.5 nM against IRAK1, IRAK4 and FLT3, respectively. IRAK1/4/pan-FLT3 Kinase-IN-1 can be used for research on AML .
loading...
    loading...
Cat. No.: HY-13493
CAS No.: 1351522-04-7
Purity:  98.56%
Target:  

PDGFR c-Kit FLT3

Research Areas:  

Cancer

AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ, respectively.
loading...
    loading...
Cat. No.: HY-155195
CAS No.: 2991054-23-8
Purity:  98.00%
Target:  

FLT3

Research Areas:  

Cancer

FLT3/CHK-IN-1 (Compound 18) is a dual inhibitor of FLT3/CHK1. FLT3/CHK-IN-1 is more than 1700 times more selective to c-KI T and greatly reduces hERG affinity with an IC50 value of 58.4 μM. FLT3/CHK-IN-1 inhibits tumor growth in mouse xenotransplantation models inoculated with MV-4-11 cells .
loading...
    loading...
Cat. No.: HY-124502
CAS No.: 1818234-19-3
Purity:  99.80%
Target:  

TAM Receptor FLT3

Research Areas:  

Cancer

UNC4203 is a potent, orally available and highly selective MERTK inhibitor, with IC50s of 1.2 nM, 140 nM, 42 nM and 90 nM for MERTK, AXL, TYRO3 and FLT3, respectively .
loading...
    loading...
Cat. No.: HY-109179A
CAS No.: 2409543-84-4
Purity:  99.43%
Synonyms: TP-0184 hydrochloride
Itacnosertib hydrochloride (TP-0184 hydrochloride) is the inhibitor for FLT3, ACVR1 (ALK2, IC50=8 nM) and JAK2 (IC50=8540 nM). Itacnosertib hydrochloride exhibits anti-leukemic activity .
loading...
    loading...
Cat. No.: HY-178858
PROTAC FLT3/CHK1 Degrader-1 is a PROTAC FLT3/CHK1 degrader, with DC50 values of 5.88 nM (FLT3) and 4.17 nM (CHK1), respectively. PROTAC FLT3/CHK1 Degrader-1 can inhibit the phosphorylation of FLT3 downstream signaling effectors STAT5 (Tyr694), AKT (Ser473), and ERK (Tyr204), downregulate the protein level of c-Myc and maintain the expression of p53 protein. PROTAC FLT3/CHK1 Degrader-1 induces Apoptosis in cells. PROTAC FLT3/CHK1 Degrader-1 shows significant anti-tumor efficacy in mice bearing MV-4-11 subcutaneous xenografts. PROTAC FLT3/CHK1 Degrader-1 can be used for the study of acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-131230
CAS No.: 2292116-14-2
Purity:  95.09%
Research Areas:  

Cancer

Desmorpholinyl Quizartinib-PEG2-COOH incorporates a ligand for FLT-3, and a PEG-based PROTAC linker. Desmorpholinyl Quizartinib-PEG2-COOH can be used in the synthesis of PROTAC FLT-3 degrader 1 (HY-114323). PROTAC FLT-3 degrader 1 is a PROTAC FLT-3 internal tandem duplication (ITD) degrader with an IC50 0.6 nM .
loading...
    loading...
Cat. No.: HY-130247B
CAS No.: 3062214-21-2
Synonyms: JAK2/Flt3-IN-1 monomaleate
Target:  

JAK FLT3 Apoptosis

Research Areas:  

Cancer

Flonoltinib maleate is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. JAK2/FLT3-IN-1 has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-175040
PROTAC FLT-3 degrader 5 is an orally active FLT3 PROTAC degrader with a DC50 of 1.2 nM. PROTAC FLT-3 degrader 5 also acts as a molecular glue to degrade GSPT1 and IKZF1/3, with DC50 values of 8.54 nM, 0.02 nM and 0.79 nM, respectively. PROTAC FLT-3 degrader 5 mediates the degradation of FLT3, GSPT1 and IKZF1/3 through interaction with the cereblon E3 ubiquitin ligase complex. PROTAC FLT-3 degrader 5 can be used in the research of acute myeloid leukemia .
loading...
    loading...